ANI Pharmaceuticals | ANIP - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
AbbVie USD 4.22B 329M 2026-03
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Assertio Holdings USD 8.89M 2.29M 2024-06
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Heron Therapeutics USD 11.12M 795K 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.54B 7M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Perrigo USD 747.4M 81.2M 2025-12
Sun Pharmaceuticals INR 36.77B 348M 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03